NXTC Insider Trading Activity and SEC Form 4 Filings
NXTC insider trading summary
Over the past 12 months, insiders at NextCure, Inc. (NXTC) reported 32 open-market purchases worth $3.5M by 2 insiders and no sales on SEC Form 4. Net insider buying was $3.5M.
Latest NXTC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 27, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $18K (3,553 @ $5.10) |
| Oct 27, 2026 | Daniel Schneeberger | 10% Owner | Buy | $18K (3,553 @ $5.10) |
| Oct 26, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $8K (1,672 @ $5.03) |
| Oct 26, 2026 | Daniel Schneeberger | 10% Owner | Buy | $8K (1,672 @ $5.03) |
| Oct 23, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $27K (5,626 @ $4.83) |
| Oct 23, 2026 | Daniel Schneeberger | 10% Owner | Buy | $27K (5,626 @ $4.83) |
| Jul 31, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $38K (8,003 @ $4.80) |
| Jul 31, 2026 | Daniel Schneeberger | 10% Owner | Buy | $16K (3,300 @ $4.98) |
| Jul 31, 2026 | Daniel Schneeberger | 10% Owner | Buy | $125K (25,000 @ $4.98) |
| Jul 31, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $16K (3,300 @ $4.98) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.